Annual Retained Earnings
-$21.48 M
+$195.78 M+90.11%
December 1, 2023
Summary
- As of February 26, 2025, CYTO annual retained earnings is -$21.48 million, with the most recent change of +$195.78 million (+90.11%) on December 1, 2023.
- During the last 3 years, CYTO annual retained earnings has risen by +$162.38 million (+88.31%).
- CYTO annual retained earnings is now -511.96% below its all-time high of -$3.51 million, reached on December 31, 2013.
Performance
CYTO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
$1.26 M
+$25.93 M+105.10%
June 1, 2024
Summary
- As of February 26, 2025, CYTO quarterly retained earnings is $1.26 million, with the most recent change of +$25.93 million (+105.10%) on June 1, 2024.
- Over the past year, CYTO quarterly retained earnings has stayed the same.
- CYTO quarterly retained earnings is now at all-time high.
Performance
CYTO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CYTO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.1% | 0.0% |
| 3 y3 years | +88.3% | 0.0% |
| 5 y5 years | +85.5% | 0.0% |
CYTO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.1% | at high | +100.6% |
| 5 y | 5-year | at high | +90.1% | at high | +100.6% |
| alltime | all time | -512.0% | +90.1% | at high | +100.6% |
Altamira Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $1.26 M(-105.1%) |
| Dec 2023 | -$21.48 M(-90.1%) | -$24.68 M(+11.8%) |
| Jun 2023 | - | -$22.07 M(-89.8%) |
| Dec 2022 | -$217.26 M(+13.0%) | -$217.26 M(+13.5%) |
| Jun 2022 | - | -$191.34 M(-0.4%) |
| Dec 2021 | -$192.20 M(+4.5%) | -$192.20 M(+7.3%) |
| Jun 2021 | - | -$179.06 M(-2.6%) |
| Dec 2020 | -$183.86 M(+16.6%) | -$183.86 M(+12.6%) |
| Jun 2020 | - | -$163.33 M(+3.6%) |
| Dec 2019 | -$157.68 M(+6.1%) | -$157.68 M(+2.9%) |
| Jun 2019 | - | -$153.26 M(+3.1%) |
| Dec 2018 | -$148.60 M(+6.3%) | -$148.60 M(+2.3%) |
| Sep 2018 | - | -$145.22 M(+3.5%) |
| Jun 2018 | - | -$140.27 M(-3.0%) |
| Mar 2018 | - | -$144.56 M(+3.4%) |
| Dec 2017 | -$139.75 M | -$139.75 M(+3.6%) |
| Sep 2017 | - | -$134.95 M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -$131.56 M(+9.3%) |
| Mar 2017 | - | -$120.40 M(+9.2%) |
| Dec 2016 | -$110.41 M(+33.8%) | -$110.27 M(-0.6%) |
| Sep 2016 | - | -$110.94 M(+9.3%) |
| Jun 2016 | - | -$101.50 M(+8.0%) |
| Mar 2016 | - | -$93.94 M(+13.8%) |
| Dec 2015 | -$82.53 M(+56.5%) | -$82.53 M(+5.0%) |
| Sep 2015 | - | -$78.63 M(+2.2%) |
| Jun 2015 | - | -$76.91 M(+23.3%) |
| Mar 2015 | - | -$62.37 M(+18.3%) |
| Dec 2014 | -$52.72 M(+1401.7%) | -$52.72 M(+5.8%) |
| Sep 2014 | - | -$49.84 M(+0.3%) |
| Jun 2014 | - | -$49.70 M(+13.2%) |
| Mar 2014 | - | -$43.92 M(+1150.9%) |
| Dec 2013 | -$3.51 M(-82.4%) | -$3.51 M |
| Dec 2012 | -$19.98 M(+37.8%) | - |
| Dec 2011 | -$14.50 M | - |
FAQ
- What is Altamira Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Altamira Therapeutics?
- What is Altamira Therapeutics annual retained earnings year-on-year change?
- What is Altamira Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly retained earnings year-on-year change?
What is Altamira Therapeutics annual retained earnings?
The current annual retained earnings of CYTO is -$21.48 M
What is the all time high annual retained earnings for Altamira Therapeutics?
Altamira Therapeutics all-time high annual retained earnings is -$3.51 M
What is Altamira Therapeutics annual retained earnings year-on-year change?
Over the past year, CYTO annual retained earnings has changed by +$195.78 M (+90.11%)
What is Altamira Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CYTO is $1.26 M
What is the all time high quarterly retained earnings for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly retained earnings is $1.26 M
What is Altamira Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CYTO quarterly retained earnings has changed by $0.00 (0.00%)